Fancd2-/- mice have hematopoietic defects that can be partially corrected by resveratrol.
about
Molecular pathogenesis and clinical management of Fanconi anemiaHallmarks of progeroid syndromes: lessons from mice and reprogrammed cellsAging of hematopoietic stem cells: DNA damage and mutations?Learning from a paradox: recent insights into Fanconi anaemia through studying mouse modelsFanconi anemia and the cell cycle: new perspectives on aneuploidyBalancing self-renewal against genome preservation in stem cells: How do they manage to have the cake and eat it too?Exonuclease 1 is a critical mediator of survival during DNA double strand break repair in nonquiescent hematopoietic stem and progenitor cells.Genotoxic consequences of endogenous aldehydes on mouse haematopoietic stem cell function.Resveratrol increases the bone marrow hematopoietic stem and progenitor cell capacityImprovement of genetic stability in lymphocytes from Fanconi anemia patients through the combined effect of α-lipoic acid and N-acetylcysteine.Modelling Fanconi anemia pathogenesis and therapeutics using integration-free patient-derived iPSCsOxymetholone therapy of fanconi anemia suppresses osteopontin transcription and induces hematopoietic stem cell cycling.GS-nitroxide (JP4-039)-mediated radioprotection of human Fanconi anemia cell lines.BRCA1 functions independently of homologous recombination in DNA interstrand crosslink repair.Disrupted Signaling through the Fanconi Anemia Pathway Leads to Dysfunctional Hematopoietic Stem Cell Biology: Underlying Mechanisms and Potential Therapeutic Strategies.Stem Cell-Specific Mechanisms Ensure Genomic Fidelity within HSCs and upon Aging of HSCs.Fetal origins of hematopoietic failure in a murine model of Fanconi anemiaTGF-β Inhibition Rescues Hematopoietic Stem Cell Defects and Bone Marrow Failure in Fanconi Anemia.Endogenous DNA Damage Leads to p53-Independent Deficits in Replicative Fitness in Fetal Murine Fancd2(-/-) Hematopoietic Stem and Progenitor Cells.Resveratrol accelerates erythroid maturation by activation of FoxO3 and ameliorates anemia in beta-thalassemic mice.Concise Review: Getting to the Core of Inherited Bone Marrow Failures.Oxidative stress-associated protein tyrosine kinases and phosphatases in Fanconi anemiaHigh incidence of female reproductive tract cancers in FA-deficient HPV16-transgenic mice correlates with E7's induction of DNA damage response, an activity mediated by E7's inactivation of pocket proteins.DNA damage response, redox status and hematopoiesis.Resilient and resourceful: genome maintenance strategies in hematopoietic stem cells.Fanconi anemia (FA) and crosslinker sensitivity: Re-appraising the origins of FA definition.Comparison of Different Cytokine Conditions Reveals Resveratrol as a New Molecule for Ex Vivo Cultivation of Cord Blood-Derived Hematopoietic Stem Cells.Recent insights into the molecular basis of Fanconi anemia: genes, modifiers, and drivers.Monoubiquitinated Fanconi anemia D2 (FANCD2-Ub) is required for BCR-ABL1 kinase-induced leukemogenesis.The Sirt1 activator SRT3025 expands hematopoietic stem and progenitor cells and improves hematopoiesis in Fanconi anemia mice.Fancd2 in vivo interaction network reveals a non-canonical role in mitochondrial function.Evaluation of resveratrol and N-acetylcysteine for cancer chemoprevention in a Fanconi anemia murine model.Fancd2 and p21 function independently in maintaining the size of hematopoietic stem and progenitor cell pool in mice.Current and emerging therapeutic strategies for Fanconi anemia.Metformin improves defective hematopoiesis and delays tumor formation in Fanconi anemia mice.Cell-Cycle-Specific Function of p53 in Fanconi Anemia Hematopoietic Stem and Progenitor Cell Proliferation.Impairment of fetal hematopoietic stem cell function in the absence of Fancd2.Resveratrol counteracts bone loss via mitofilin-mediated osteogenic improvement of mesenchymal stem cells in senescence-accelerated mice.Lnk/Sh2b3 deficiency restores hematopoietic stem cell function and genome integrity in Fancd2 deficient Fanconi anemia
P2860
Q24621696-34909D04-F2C5-4459-967C-F721C500022AQ26740026-0125AA6E-D58C-45E3-9C6E-B0CC44EF0115Q26741217-02D10B12-877D-4CC5-B080-BC2F925CA883Q26863356-FF94A517-65CD-4C9A-9782-9AB947B92186Q27014905-D5AC1700-6DB0-4B79-A930-909D7760C020Q28070584-CF2678C5-5DB2-445D-822F-925752ED31CBQ33573646-E6E400B5-E366-4421-8FA3-E4AC0B669CB8Q34295969-C62F59CB-E0ED-415A-B61B-CE5538B5F8D2Q34543377-5196F3B7-C1DF-45A9-847D-EAE9A7904F7CQ34638291-7F7BE272-4BBB-45FA-91C8-816A4870C900Q34918292-2DEE8C77-6B07-4287-804C-80C930BA9C55Q34980734-7F5E601D-C980-4EF8-846F-24CFD3F6FC51Q35532416-EEB2C9F1-ABF3-4C6B-9F5B-38113ECA11E9Q35923364-E6C99F53-9B61-4852-BB45-1833283004AFQ36004703-1F953CE7-A243-4C5E-BAAA-02ED32FCC664Q36405518-90387A21-5095-4304-B18D-B5ADB0EA38CBQ36818532-D9558219-F07B-4DE9-8E11-74548B432214Q36880474-D3C5D540-3BE1-4389-9674-24C6ED8A029EQ37410118-7D5F969B-5577-453D-8679-A077FD391039Q37552018-3D2EF262-6FF0-4169-ADCF-A54AF83F6424Q37633372-51B9AB9F-E005-4CA2-8CDA-C33D207DFA6BQ37716059-6FF1DB53-732F-48F3-93A3-DDEBFFFCD7CEQ37722678-829D1B40-D937-47C9-84B7-61915388C45DQ38138224-54B4F97C-F2C5-4E86-9587-D6B9CA761CCEQ38143364-E47A0F00-4BF6-4DE5-8811-FCCA5122C076Q38366827-E960EAAF-D0F2-4949-9F24-30662167C9FBQ38986290-7D37EF75-11C2-46B2-879B-6BD8741BE6CAQ39385071-678CE274-3A6B-4D8A-907B-07651A9700FCQ39553171-73B2D578-1E07-4239-AA3C-CF72290DF36EQ40866536-AE32778D-014B-4055-BBE2-B9D150390F5DQ41840189-517A8CC2-F63A-4F03-8310-71E14B857167Q42008623-38FB4F51-B93C-440A-A495-C104471D223BQ42544774-45CE9DBA-6037-489A-979E-BB6B9EF19359Q45871170-C7C0D277-8117-49C1-B18D-7DA5C68D5A4EQ48291324-8A4A0DEF-7B5E-4A02-88A9-9571AD2A4ACDQ50145228-F811128C-B330-4DDD-ACC2-92684A4A1E55Q51286905-E76BD1A3-D688-4195-B430-11FBFC07AB28Q55081996-F1818DFB-51BF-4964-9193-36A8483A7FBAQ58698752-18C79065-3DB6-4670-AB89-03FE99DA252D
P2860
Fancd2-/- mice have hematopoietic defects that can be partially corrected by resveratrol.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Fancd2-/- mice have hematopoietic defects that can be partially corrected by resveratrol.
@en
type
label
Fancd2-/- mice have hematopoietic defects that can be partially corrected by resveratrol.
@en
prefLabel
Fancd2-/- mice have hematopoietic defects that can be partially corrected by resveratrol.
@en
P2093
P2860
P50
P1433
P1476
Fancd2-/- mice have hematopoietic defects that can be partially corrected by resveratrol
@en
P2093
Andrew W Duncan
Devorah C Goldman
Grover C Bagby
Laura Eaton
Laura Marquez-Loza
Praveen Anur
R Keaney Rathbun
William H Fleming
P2860
P304
P356
10.1182/BLOOD-2010-04-278226
P407
P577
2010-09-08T00:00:00Z